
LY2183240
CAS No. 874902-19-9
LY2183240( —— )
Catalog No. M24889 CAS No. 874902-19-9
LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 35 | In Stock |
![]() ![]() |
10MG | 58 | In Stock |
![]() ![]() |
25MG | 120 | In Stock |
![]() ![]() |
50MG | 228 | In Stock |
![]() ![]() |
100MG | 356 | In Stock |
![]() ![]() |
500MG | 836 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameLY2183240
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM).
-
DescriptionLY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM).
-
In Vitro——
-
In VivoLY2183240 (3-30mg/kg; i.p.) dose-dependently attenuates formalin-induced paw-licking pain behavior in the formalin model of persistent pain mechanisms. Animal Model:Male Sprague-Dawley rats (Formalin Pain Model)Dosage:3, 10, 30 mg/kg Administration:I.p.Result:Dose-dependently attenuated formalin-induced paw-licking pain behavior in the formalin model of persistent pain mechanisms.
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy|FAAH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number874902-19-9
-
Formula Weight307.35
-
Molecular FormulaC17H17N5O
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (162.68 mM; Need ultrasonic)
-
SMILESO=C(N(C)C)N1N=NN=C1CC(C=C2)=CC=C2C3=CC=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dickason-Chesterfield AK, et al. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors. Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):407-23.
molnova catalog



related products
-
O4I1
O4I1 is an effective Oct3/4 inducer.
-
SJFα
SJFα (SJF alpha) is a PROTAC formed by an E3 ubiquitin ligase-conjugated protein hydrolysis regulator that degrades p38α and p38δ and can be used in cancer research.
-
Nilotinib hydrochlor...
Nilotinib hydrochloride(AMN-107 HCl) is an orally available Bcr-Abl tyrosine kinase inhibitor with antitumor activity for modulation of neuroinflammation and cognitive deficits, and may be used in studies of chronic myelogenous leukemia.